← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 12, 2012Last known activity
Apr 15, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT04849429Overall official - principal investigatorPhase 1Apr 15, 2021
- NCT04849429Reponsible party - principal investigatorPhase 1Apr 15, 2021
- NCT04849429Lead sponsorPhase 1Apr 15, 2021
- NCT04340284Lead sponsorPhase 1/Phase 2Nov 10, 2019
- NCT02742857CollaboratorPhase 1Jul 1, 2017
- NCT05484856Lead sponsorPhase 1/Phase 2May 16, 2016
- NCT05484856Reponsible party - principal investigatorPhase 1/Phase 2May 16, 2016
- NCT04198467Lead sponsorPhase 2Oct 21, 2014
- NCT04198467Overall official - principal investigatorPhase 2Oct 21, 2014
- NCT03089762CollaboratorPhase 1Feb 12, 2012
Details
- Last known activity
- Apr 15, 2021